Liver Enzymes: Potential Cardiovascular Risk Markers?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|33|3632-3643

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.33, 2011-11, pp. : 3632-3643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural, Biochemical and Non-Traditional Cardiovascular Risk Markers in PCOS

By  

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5764-5774

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular Damage)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2335-2340

Bentham Science Publishers

Access to resources Recommend Favorite

Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 4, 2008-12 ,pp. : 301-307

Bentham Science Publishers

Access to resources Recommend Favorite

Renal dysfunction: a novel indicator and potential promoter of cardiovascular risk

By Ritz Eberhard  

Clinical Medicine, Vol. 3, Iss. 4, 2003-07 ,pp. : 357-360

Royal College Of Physicians

Access to resources Recommend Favorite

Potential Mechanisms of COX-2 Selective Inhibitors Affecting Cardiovascular Risk

By Smith Howard S.  

Journal of Cancer Pain & Symptom Palliation, Vol. 2, Iss. 3, 2008-01 ,pp. : 5-18

Haworth Press

Access to resources Recommend Favorite